CEO J. Eric Evans was paid $6,083,862 in fiscal year 2025, ↓ down 5.8% from fiscal year 2024, the 27th percentile of its disclosed peer group (SEC filing 0001638833-26-000039 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$6,083,862 ↓ J. Eric Evans total, FY2025 | 27th CEO pay percentile vs peers | 112:1 CEO-to-median pay ratio | 98.22% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
SGRY's next annual pay disclosure, estimated April 22, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| J. Eric Evans | $1,050,000 | $0 | $5,000,000 | $0 | $0 | $11,520 | $22,342 | $6,083,862 |
| Chief Executive Officer | ||||||||
| David Doherty | 666,154 | 0 | 2,000,000 | 0 | 0 | 0 | 10,500 | 2,676,654 |
| Executive Vice President and Chief Financial Officer | ||||||||
| Jennifer Baldock | 614,538 | 0 | 1,500,000 | 0 | 0 | 45,556 | 23,500 | 2,183,594 |
| Executive Vice President, Chief Administrative and Development Officer | ||||||||
| Harrison Bane | 466,346 | 0 | 1,025,000 | 0 | 0 | 0 | 9,049 | 1,500,395 |
| Former President, National Group | ||||||||
| W. Trent Webb | 510,577 | 0 | 750,000 | 0 | 0 | 0 | 9,775 | 1,270,352 |
| President, American Group | ||||||||
| Marissa Brittenham | 512,115 | 0 | 600,000 | 0 | 0 | 0 | 11,000 | 1,123,115 |
| Executive Vice President and Chief Strategy Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| J. Eric Evans | $6,083,862 | $6,461,203 | $6,457,600 | ↓ −377,341 |
| David Doherty | 2,676,654 | 3,231,889 | 3,519,100 | ↓ −555,235 |
| Jennifer Baldock | 2,183,594 | 2,685,090 | 3,088,695 | ↓ −501,496 |
| Harrison Bane | 1,500,395 | 1,776,350 | 1,590,904 | ↓ −275,955 |
| W. Trent Webb | 1,270,352 | — | — | — |
| Marissa Brittenham | 1,123,115 | 1,456,042 | 1,677,292 | ↓ −332,927 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Surgery Partners's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper SGRY reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
The list of companies that name SGRY as a peer is temporarily unavailable — recheck shortly.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Andrew T. Kaplan | Independent Director | — |
| Blair E. Hendrix | Chair of the Board | $345,000 |
| Brent Turner | Independent Director | $465,000 |
| Clifford G. Adlerz | Independent Director | $260,000 |
| Devin O'Reilly | Independent Director | — |
| John A. Deane | Independent Director | $410,000 |
| Laura L. Forese, M.D | Independent Director | $410,000 |
| Lloyd Dean | Independent Director | — |
| Patricia A. Maryland, Dr.PH | Former director (through FY2025) | $385,000 |
| Teresa DeLuca, M.D | Independent Director | $430,000 |
| Wayne S. DeVeydt | Former director (through FY2025) | $125,000 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Brent Turner | Director | 2026-06-05 | A | 11,670 | $14 | $159,996 | Common | Form 4 ↗ |
| Teresa DeLuca | Director | 2026-06-05 | A | 11,670 | 14 | 159,996 | Common | Form 4 ↗ |
| Lloyd Dean | Director | 2026-06-05 | A | 11,670 | 14 | 159,996 | Common | Form 4 ↗ |
| Laura L. Forese | Director | 2026-06-05 | A | 11,670 | 14 | 159,996 | Common | Form 4 ↗ |
| John A. Deane | Director | 2026-06-05 | A | 11,670 | 14 | 159,996 | Common | Form 4 ↗ |
| Blair E. Hendrix | Director | 2026-06-05 | A | 11,670 | 14 | 159,996 | Common | Form 4 ↗ |
| Clifford G. Adlerz | Director | 2026-06-05 | A | 11,670 | 14 | 159,996 | Common | Form 4 ↗ |
| Blair E. Hendrix | Director | 2026-06-18 | A | 34,364 | 15 | 499,996 | Common | Form 4 ↗ |
| Teresa DeLuca | Director | 2026-08-18 | A | 10,000 | 14 | 143,500 | Common | Form 4 ↗ |
| Teresa DeLuca | Director | 2026-08-18 | A | 11,250 | 14 | 161,213 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| David Doherty | PSU | 2025-03-04 | 50,420 | 100,840 | — | 151,260 | $1,200,000 |
| Marissa Brittenham | Restricted Stock | 2025-03-04 | — | — | 10,084 | — | 240,000 |
| W. Trent Webb | Restricted Stock | 2025-03-04 | — | — | 12,605 | — | 300,000 |
| J. Eric Evans | Restricted Stock | 2025-03-04 | — | — | 84,033 | — | 2,000,000 |
| David Doherty | Restricted Stock | 2025-03-04 | — | — | 33,613 | — | 800,000 |
| Harrison Bane | Restricted Stock | 2025-03-04 | — | — | 17,226 | — | 410,000 |
| Jennifer Baldock | Restricted Stock | 2025-03-04 | — | — | 25,210 | — | 600,000 |
| Jennifer Baldock | PSU | 2025-03-04 | 37,815 | 75,630 | — | 113,445 | 900,000 |
| W. Trent Webb | PSU | 2025-03-04 | 18,907 | 37,814 | — | 56,721 | 450,000 |
| Harrison Bane | PSU | 2025-03-04 | 25,840 | 51,680 | — | 77,520 | 615,000 |
| Marissa Brittenham | PSU | 2025-03-04 | 15,126 | 30,252 | — | 45,378 | 360,000 |
| J. Eric Evans | PSU | 2025-03-04 | 126,050 | 252,100 | — | 378,150 | 3,000,000 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| David Doherty | $0 | $1,200,000 | $0 | 100.0% |
| Marissa Brittenham | 0 | 360,000 | 0 | 100.0% |
| W. Trent Webb | 0 | 450,000 | 0 | 100.0% |
| J. Eric Evans | 0 | 3,000,000 | 0 | 100.0% |
| Harrison Bane | 0 | 615,000 | 0 | 100.0% |
| Jennifer Baldock | 0 | 900,000 | 0 | 100.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| J. Eric Evans | RSU | 84,033 | — | $1,298,310 |
| Marissa Brittenham | RSU | 2,537 | — | 39,197 |
| W. Trent Webb | RSU | 1,015 | — | 15,682 |
| David Doherty | RSU | 38,486 | — | 594,609 |
| W. Trent Webb | RSU | 3,207 | — | 49,548 |
| J. Eric Evans | RSU | 22,318 | — | 344,813 |
| Jennifer Baldock | RSU | 25,210 | — | 389,495 |
| W. Trent Webb | RSU | 561 | — | 8,667 |
| David Doherty | RSU | 50,420 | — | 778,989 |
| Jennifer Baldock | RSU | 22,824 | — | 352,631 |
| J. Eric Evans | RSU | 126,050 | — | 1,947,473 |
| David Doherty | RSU | 21,302 | — | 329,116 |
| Jennifer Baldock | RSU | 28,864 | — | 445,949 |
| David Doherty | RSU | 33,613 | — | 519,321 |
| W. Trent Webb | RSU | 18,907 | — | 292,113 |
| Jennifer Baldock | RSU | 18,259 | — | 282,102 |
| Marissa Brittenham | RSU | 15,216 | — | 235,087 |
| W. Trent Webb | RSU | 12,605 | — | 194,747 |
| David Doherty | RSU | 7,101 | — | 109,710 |
| Marissa Brittenham | RSU | 6,302 | — | 97,366 |
| Marissa Brittenham | RSU | 10,084 | — | 155,798 |
| Jennifer Baldock | RSU | 6,087 | — | 94,044 |
| Marissa Brittenham | RSU | 15,126 | — | 233,697 |
| David Doherty | RSU | 17,105 | — | 264,272 |
| Marissa Brittenham | RSU | 5,132 | — | 79,289 |
| J. Eric Evans | RSU | 84,669 | — | 1,308,136 |
| J. Eric Evans | RSU | 66,950 | — | 1,034,378 |
| Jennifer Baldock | RSU | 37,815 | — | 584,242 |
| J. Eric Evans | RSU | 37,631 | — | 581,399 |
| David Doherty | RSU | 30,432 | — | 470,174 |
| J. Eric Evans | RSU | 29,411 | — | 454,400 |
| David Doherty | RSU | 15,126 | — | 233,697 |
| Jennifer Baldock | RSU | 14,285 | — | 220,703 |
| Marissa Brittenham | RSU | 11,545 | — | 178,370 |
| Jennifer Baldock | RSU | 12,829 | — | 198,208 |
| Marissa Brittenham | RSU | 7,608 | — | 117,544 |
| W. Trent Webb | RSU | 3,781 | — | 58,416 |
| W. Trent Webb | RSU | 2,816 | — | 43,507 |
| W. Trent Webb | RSU | 1,522 | — | 23,515 |
| W. Trent Webb | RSU | 2,139 | — | 33,048 |
| Marissa Brittenham | RSU | 1,443 | — | 22,294 |
| W. Trent Webb | RSU | 1,252 | — | 19,343 |
The executive compensation program reflects a commitment to pay-for-performance and aligning management interests with stockholders, with a significant portion of total direct compensation weighted toward performance-based incentives that drive both short-term financial goals and long-term stockholder value creation.
| CEO STI target (% of salary) | 120% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Frederic W. Cook & Co., Inc. (FW Cook) |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | false |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-05 | 111,639,092 | 2,018,777 | 15,275 | 98.22% | Passed |
| 2025 | 2025-06-06 | 96,577,058 | 19,241,638 | 28,193 | 83.39% | Passed |
| 2024 | 2024-06-06 | 121,165,656 | 1,057,012 | 114,380 | 99.14% | Passed |
| 2023 | 2023-06-01 | 118,127,561 | 3,307,178 | 7,989 | 97.28% | Passed |
| 2022 | 2022-05-19 | 84,240,342 | 1,818,124 | 49,114 | 97.89% | Passed |
| 2021 | 2021-05-26 | 76,699,550 | 591,435 | 27,464 | 99.23% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-05 | 98.22%a |
| 2025 | 2025-06-06 | 83.39%b |
| 2024 | 2024-06-06 | 99.14%c |
a. Approved under the standard stated in the filing — “Abstentions will have no effect on the outcome of this Proposal 3.”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of this proposal.”.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of this proposal.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 112 : 1 |
|---|---|
| CEO total compensation | $6,083,862 |
| Median employee compensation | $54,477 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Brent TurnerIndependent · Audit (Chair) · Compensation | $305,000 | $160,000 | $0 | $0 | $0 | $465,000 |
| Teresa DeLuca, M.DIndependent · Audit · Compliance and Ethics (Chair) | 270,000 | 160,000 | 0 | 0 | 0 | 430,000 |
| John A. DeaneIndependent · Audit · Compensation | 250,000 | 160,000 | 0 | 0 | 0 | 410,000 |
| Laura L. Forese, M.DIndependent · Compliance and Ethics · Nominating and Corporate Governance | 250,000 | 160,000 | 0 | 0 | 0 | 410,000 |
| Patricia A. Maryland, Dr.PHIndependent · Nominating and Corporate Governance · Compliance and Ethics · Departed during FY | 225,000 | 160,000 | 0 | 0 | 0 | 385,000 |
| Blair E. HendrixIndependent · Board Chair · Nominating and Corporate Governance (Chair) | 185,000 | 160,000 | 0 | 0 | 0 | 345,000 |
| Clifford G. AdlerzIndependent · Compliance and Ethics | 100,000 | 160,000 | 0 | 0 | 0 | 260,000 |
| Wayne S. DeVeydtNot independent · Departed during FY | 125,000 | — | 0 | 0 | 0 | 125,000 |
| Lloyd DeanIndependent · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Devin O'ReillyIndependent · Compensation (Chair) · Nominating and Corporate Governance | 0 | 0 | 0 | 0 | 0 | 0 |
| Andrew T. KaplanIndependent · Compensation | 0 | 0 | 0 | 0 | 0 | 0 |
| J. Eric EvansEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $100,000 |
|---|---|
| Annual equity retainer | $160,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 20,000 |
| Stock ownership guideline | 5x annual retainer ($500,000) |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,710,000 |
| Equity awards (grant-date value) | $1,120,000 |
| All other compensation | $0 |
| Total cost of the board | $2,830,000 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Surgery Partners names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Surgery Partners.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | The Ensign Group, Inc. | 2025 | Barry Port | $549,264 | $2,912,355 | $0 | $10,317,247 | $13,804,700 |
| 2 | Chemed Corporation | 2025 | Kevin McNamara | 1,858,792 | 2,883,553 | 5,036,021 | 1,486,976 | 12,904,720 |
| 3 | RadNet, Inc. | 2025 | Howard Berger | 3,000,000 | 8,999,966 | 0 | 0 | 12,087,934 |
| 4 | Premier, Inc. | 2024 | Michael Alkire | 1,095,876 | 8,500,039 | 0 | 1,800,150 | 11,806,381 |
| 5 | AMN Healthcare Services, Inc. | 2025 | Cary Grace | 1,060,000 | 8,363,117 | 0 | 1,146,125 | 10,669,780 |
| 6 | Encompass Health Corporation | 2025 | Mark Tarr | 1,100,000 | 5,285,381 | 1,165,376 | 2,581,525 | 10,297,258 |
| 7 | Option Care Health, Inc. | 2025 | John Rademacher | 1,000,000 | 6,500,050 | 0 | 1,665,000 | 9,266,330 |
| 8 | Acadia Healthcare Company, Inc. | 2025 | Christopher Hunter | 1,061,000 | 5,712,012 | 0 | 1,135,270 | 7,909,463 |
| 9 | Surgery Partners | 2025 | J. Eric Evans | 1,050,000 | 5,000,000 | 0 | 0 | 6,083,862 |
| 10 | Brookdale Senior Living Inc. | 2025 | Nikolas Stengle | 229,310 | 4,283,968 | 0 | 403,571 | 5,307,655 |
| 11 | Select Medical Holdings Corp | 2025 | Thomas Mullin | 618,000 | 1,425,000 | 0 | 939,360 | 3,042,527 |
| 12 | Pediatrix Medical Group, Inc. | 2025 | James Swift | 54,167 | 730,720 | 0 | 68,981 | 2,775,881 |
| — | Amedisys, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | ModivCare Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Surgery Partners | not disclosed | PSU 60 · Restricted Stock 40 | No | Frederic W. Cook & Co., Inc. (FW Cook) |
| Acadia Healthcare Company, Inc. | 85.6% | PSU 50 · RSU 50 | No | WTW |
| Amedisys, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| AMN Healthcare Services, Inc. | 87% | not disclosed | Yes — Relative TSR | FW Cook |
| Brookdale Senior Living Inc. | 125.7% | not disclosed | No | F.W. Cook & Co., Inc. |
| Chemed Corporation | not disclosed | not disclosed | Yes — 3-Year Relative Total Shareholder Return (TSR) | Compensation Strategies, Inc. |
| Encompass Health Corporation | 173.8% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| ModivCare Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Option Care Health, Inc. | 111% | PSU 60 · RSU 40 | No | Pearl Meyer |
| Pediatrix Medical Group, Inc. | 180% | PSU 50 · RSU 50 | No | Semler Brossy Consulting Group |
| Premier, Inc. | 109.1% | PSU 60 · RSU 40 | No | Mercer |
| RadNet, Inc. | not disclosed | RSU 100 | No | Pearl Meyer |
| Select Medical Holdings Corp | 190% | RSU 100 | not disclosed | not disclosed |
| The Ensign Group, Inc. | not disclosed | not disclosed | not disclosed | Willis Towers Watson |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, J. Eric Evans | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Summary Compensation Table”. As printed: 6,083,862. Filing ↗machine: r2 · c24 · span 365862–365872 |
| 2 | Section 01, David Doherty | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Summary Compensation Table”. As printed: 2,676,654. Filing ↗machine: r5 · c24 · span 371945–371954 |
| 3 | Section 01, Jennifer Baldock | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Summary Compensation Table”. As printed: 2,183,594. Filing ↗machine: r8 · c24 · span 378077–378086 |
| 4 | Section 01, Harrison Bane | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Summary Compensation Table”. As printed: 1,500,395. Filing ↗machine: r15 · c24 · span 392620–392629 |
| 5 | Section 01, W. Trent Webb | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Summary Compensation Table”. As printed: 1,270,352. Filing ↗machine: r14 · c24 · span 390185–390194 |
| 6 | Section 01, Marissa Brittenham | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Summary Compensation Table”. As printed: 1,123,115. Filing ↗machine: r11 · c24 · span 384156–384165 |
| 7 | Section 03, David Doherty PSU | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r10 · c9 · span 463968–463977 |
| 8 | Section 03, Marissa Brittenham Restricted Stock | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r16 · c9 · span 479860–479867 |
| 9 | Section 03, W. Trent Webb Restricted Stock | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r20 · c9 · span 490229–490236 |
| 10 | Section 03, J. Eric Evans Restricted Stock | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r4 · c9 · span 448658–448667 |
| 11 | Section 03, David Doherty Restricted Stock | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r8 · c9 · span 459054–459061 |
| 12 | Section 03, Harrison Bane Restricted Stock | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r24 · c9 · span 500578–500585 |
| 13 | Section 03, Jennifer Baldock Restricted Stock | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r12 · c9 · span 469516–469523 |
| 14 | Section 03, Jennifer Baldock PSU | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r14 · c9 · span 474888–474895 |
| 15 | Section 03, W. Trent Webb PSU | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r22 · c9 · span 495639–495646 |
| 16 | Section 03, Harrison Bane PSU | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r26 · c9 · span 505454–505461 |
| 17 | Section 03, Marissa Brittenham PSU | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r18 · c6 · span 484079–484085 |
| 18 | Section 03, J. Eric Evans PSU | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t15 · r6 · c9 · span 454145–454154 |
| 19 | Section 07, pay ratio | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “CEO Pay Ratio”. As printed: 112 : 1. Filing ↗machine: span 732773–732776 |
| 20 | Section 08, Brent Turner | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Director Compensation”. As printed: 465,000. Filing ↗machine: t24 · r3 · c3 · span 825748–825874 |
| 21 | Section 08, Teresa DeLuca, M.D | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Director Compensation”. As printed: 430,000. Filing ↗machine: t24 · r4 · c3 · span 826798–826924 |
| 22 | Section 08, John A. Deane | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Director Compensation”. As printed: 410,000. Filing ↗machine: t24 · r5 · c3 · span 827839–827965 |
| 23 | Section 08, Laura L. Forese, M.D | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Director Compensation”. As printed: 410,000. Filing ↗machine: span 832376–832502 |
| 24 | Section 08, Patricia A. Maryland, Dr.PH | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Director Compensation”. As printed: 385,000. Filing ↗machine: t24 · r10 · c3 · span 833566–833692 |
| 25 | Section 08, Blair E. Hendrix | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Director Compensation”. As printed: 345,000. Filing ↗machine: t24 · r11 · c3 · span 834568–834694 |
| 26 | Section 08, Clifford G. Adlerz | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Director Compensation”. As printed: 260,000. Filing ↗machine: t24 · r6 · c3 · span 828900–829026 |
| 27 | Section 08, Wayne S. DeVeydt | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Director Compensation”. As printed: 125,000. Filing ↗machine: t24 · r2 · c1 · span 824169–824296 |
| 28 | Section 08, Lloyd Dean | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 29 | Section 08, Devin O'Reilly | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Director Compensation”. As printed: 0. Filing ↗machine: t24 · r7 · c3 · span 830170–830171 |
| 30 | Section 08, Andrew T. Kaplan | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Director Compensation”. As printed: 0. Filing ↗machine: t24 · r8 · c3 · span 831409–831410 |
| 31 | Section 08, J. Eric Evans | DEF 14A | 2026-04-23 | 0001638833-26-000039 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 32 | Section 02, Brent Turner 2026-06-05 | Form 4 | 2026-06-09 | 0001638833-26-000057 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Teresa DeLuca 2026-06-05 | Form 4 | 2026-06-09 | 0001638833-26-000058 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Lloyd Dean 2026-06-05 | Form 4 | 2026-06-09 | 0001638833-26-000059 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Laura L. Forese 2026-06-05 | Form 4 | 2026-06-09 | 0001638833-26-000061 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, John A. Deane 2026-06-05 | Form 4 | 2026-06-09 | 0001638833-26-000062 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Blair E. Hendrix 2026-06-05 | Form 4 | 2026-06-09 | 0001638833-26-000064 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Clifford G. Adlerz 2026-06-05 | Form 4 | 2026-06-09 | 0001638833-26-000060 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Blair E. Hendrix 2026-06-18 | Form 4 | 2026-07-14 | 0001638833-26-000066 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Teresa DeLuca 2026-08-18 | Form 4 | 2026-08-19 | 0001638833-26-000079 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Teresa DeLuca 2026-08-18 | Form 4 | 2026-08-20 | 0001638833-26-000081 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 06, 2026 vote | Form 8-K | 2026-06-05 | 0001638833-26-000050 | Item 5.07 · say-on-pay result. As reported: 98.22% (votes for as printed: 111,639,092). Filing ↗ |
| 43 | Section 06, 2025 vote | Form 8-K | 2025-06-06 | 0001638833-25-000096 | Item 5.07 · say-on-pay result. As reported: 83.39% (votes for as printed: 96,577,058). Filing ↗ |
| 44 | Section 06, 2024 vote | Form 8-K | 2024-06-11 | 0001638833-24-000127 | Item 5.07 · say-on-pay result. As reported: 99.14% (votes for as printed: 121,165,656). Filing ↗ |
| 45 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 46 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 47 | Section 09b board cost (computed) | Computed | — | — | Cash 1,710,000 + equity 1,120,000 + all other 0 = 2,830,000, summed across the director compensation table rows.machine: formula: Σ = 2,830,000 |
| 48 | The Ensign Group, Inc., Section 10b CEO total | DEF 14A | 2026-04-02 | 0001125376-26-000014 | CEO total compensation as printed in The Ensign Group, Inc.'s own proxy. As printed: 13,804,700. Filing ↗machine: span 521316–521326 |
| 49 | Chemed Corporation, Section 10b CEO total | DEF 14A | 2026-04-09 | 0001562762-26-000052 | CEO total compensation as printed in Chemed Corporation's own proxy. As printed: 12,904,720. Filing ↗ |
| 50 | RadNet, Inc., Section 10b CEO total | DEF 14A | 2026-04-20 | 0001683168-26-003086 | CEO total compensation as printed in RadNet, Inc.'s own proxy. As printed: 12,087,934. Filing ↗machine: t93 · r1 · c26 · span 428610–428620 |
| 51 | Premier, Inc., Section 10b CEO total | DEF 14A | 2024-10-21 | 0001193125-24-240399 | CEO total compensation as printed in Premier, Inc.'s own proxy. As printed: 11,806,381. Filing ↗machine: span 1173351–1173361 |
| 52 | AMN Healthcare Services, Inc., Section 10b CEO total | DEF 14A | 2026-03-18 | 0001104659-26-029908 | CEO total compensation as printed in AMN Healthcare Services, Inc.'s own proxy. As printed: 10,669,780. Filing ↗machine: t94 · r1 · c42 · span 1287064–1287074 |
| 53 | Encompass Health Corporation, Section 10b CEO total | DEF 14A | 2026-04-07 | 0000785161-26-000105 | CEO total compensation as printed in Encompass Health Corporation's own proxy. As printed: 10,297,258. Filing ↗machine: r2 · c48 · span 734470–734480 |
| 54 | Option Care Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-08 | 0001140361-26-013825 | CEO total compensation as printed in Option Care Health, Inc.'s own proxy. As printed: 9,266,330. Filing ↗machine: r2 · c25 · span 1114074–1114083 |
| 55 | Acadia Healthcare Company, Inc., Section 10b CEO total | DEF 14A | 2026-03-25 | 0001140361-26-011130 | CEO total compensation as printed in Acadia Healthcare Company, Inc.'s own proxy. As printed: 7,909,463. Filing ↗ |
| 56 | Surgery Partners (subject), Section 10b CEO total | DEF 14A | 2026-04-23 | 0001638833-26-000039 | CEO total compensation as printed in Surgery Partners's own proxy. As printed: 6,083,862. Filing ↗machine: r2 · c24 · span 365862–365872 |
| 57 | Brookdale Senior Living Inc., Section 10b CEO total | DEF 14A | 2026-04-30 | 0001193125-26-197412 | CEO total compensation as printed in Brookdale Senior Living Inc.'s own proxy. As printed: 5,307,655. Filing ↗machine: r4 · c27 · span 1161767–1161776 |
| 58 | Select Medical Holdings Corp, Section 10b CEO total | DEF 14A | 2026-03-04 | 0001104659-26-023205 | CEO total compensation as printed in Select Medical Holdings Corp's own proxy. As printed: 3,042,527. Filing ↗machine: r13 · c41 · span 384685–384694 |
| 59 | Pediatrix Medical Group, Inc., Section 10b CEO total | DEF 14A | 2026-03-27 | 0001193125-26-127299 | CEO total compensation as printed in Pediatrix Medical Group, Inc.'s own proxy. As printed: 2,775,881. Filing ↗machine: r22 · c24 · span 1960691–1960700 |
| 60 | Section 10a, Acadia Healthcare Company, Inc. reciprocity | DEF 14A | — | 0001140361-26-011130 | Acadia Healthcare Company, Inc.'s most recent proxy was read; its disclosed peer group does not include Surgery Partners. Filing ↗ |
| 61 | Section 10a, Encompass Health Corporation reciprocity | DEF 14A | — | 0000785161-26-000105 | Encompass Health Corporation names Surgery Partners in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 62 | Section 10a, Premier, Inc. reciprocity | DEF 14A | — | 0001193125-24-240399 | Premier, Inc.'s most recent proxy was read; its disclosed peer group does not include Surgery Partners. Filing ↗ |
| 63 | Section 10a, The Ensign Group, Inc. reciprocity | DEF 14A | — | 0001125376-26-000014 | The Ensign Group, Inc.'s most recent proxy was read; its disclosed peer group does not include Surgery Partners. Filing ↗ |
| 64 | Section 10a, RadNet, Inc. reciprocity | DEF 14A | — | 0001683168-26-003086 | RadNet, Inc. names Surgery Partners in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 65 | Section 10a, Option Care Health, Inc. reciprocity | DEF 14A | — | 0001140361-26-013825 | Option Care Health, Inc. names Surgery Partners in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 66 | Section 10a, Chemed Corporation reciprocity | DEF 14A | — | 0001562762-26-000052 | Chemed Corporation names Surgery Partners in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 67 | Section 10a, Brookdale Senior Living Inc. reciprocity | DEF 14A | — | 0001193125-26-197412 | Brookdale Senior Living Inc. names Surgery Partners in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 68 | Section 10a, AMN Healthcare Services, Inc. reciprocity | DEF 14A | — | 0001104659-26-029908 | AMN Healthcare Services, Inc.'s most recent proxy was read; its disclosed peer group does not include Surgery Partners. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.